A detailed history of Blair William & CO transactions in Catalent, Inc. stock. As of the latest transaction made, Blair William & CO holds 38,980 shares of CTLT stock, worth $2.47 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
38,980
Previous 39,706 1.83%
Holding current value
$2.47 Million
Previous $2.23 Million 5.78%
% of portfolio
0.01%
Previous 0.01%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$56.16 - $60.96 $40,772 - $44,256
-726 Reduced 1.83%
38,980 $2.36 Million
Q2 2024

Aug 12, 2024

SELL
$53.58 - $57.02 $122,805 - $130,689
-2,292 Reduced 5.46%
39,706 $2.23 Million
Q1 2024

May 09, 2024

BUY
$42.56 - $59.82 $51,923 - $72,980
1,220 Added 2.99%
41,998 $2.37 Million
Q4 2023

Feb 12, 2024

SELL
$32.18 - $46.57 $827,701 - $1.2 Million
-25,721 Reduced 38.68%
40,778 $1.83 Million
Q3 2023

Nov 09, 2023

SELL
$44.2 - $50.2 $208,933 - $237,295
-4,727 Reduced 6.64%
66,499 $3.03 Million
Q2 2023

Aug 11, 2023

SELL
$31.86 - $67.26 $919,097 - $1.94 Million
-28,848 Reduced 28.83%
71,226 $3.09 Million
Q1 2023

May 12, 2023

BUY
$45.44 - $74.26 $3.03 Million - $4.95 Million
66,658 Added 199.48%
100,074 $6.58 Million
Q4 2022

Feb 10, 2023

BUY
$41.39 - $81.0 $116,471 - $227,934
2,814 Added 9.2%
33,416 $1.5 Million
Q3 2022

Nov 09, 2022

SELL
$72.36 - $113.1 $31,404 - $49,085
-434 Reduced 1.4%
30,602 $2.21 Million
Q2 2022

Aug 10, 2022

SELL
$87.2 - $114.05 $62,958 - $82,344
-722 Reduced 2.27%
31,036 $3.33 Million
Q1 2022

May 13, 2022

SELL
$94.19 - $124.49 $19,026 - $25,146
-202 Reduced 0.63%
31,758 $3.52 Million
Q4 2021

Feb 14, 2022

BUY
$119.57 - $139.07 $248,586 - $289,126
2,079 Added 6.96%
31,960 $4.09 Million
Q3 2021

Nov 12, 2021

BUY
$109.17 - $142.35 $69,541 - $90,676
637 Added 2.18%
29,881 $3.98 Million
Q2 2021

Aug 12, 2021

SELL
$100.34 - $115.69 $81,777 - $94,287
-815 Reduced 2.71%
29,244 $3.16 Million
Q1 2021

May 13, 2021

SELL
$101.51 - $125.27 $83,339 - $102,846
-821 Reduced 2.66%
30,059 $3.17 Million
Q4 2020

Feb 09, 2021

SELL
$85.88 - $105.36 $69,476 - $85,236
-809 Reduced 2.55%
30,880 $3.21 Million
Q3 2020

Nov 06, 2020

SELL
$72.74 - $92.5 $506,270 - $643,800
-6,960 Reduced 18.01%
31,689 $2.71 Million
Q2 2020

Aug 12, 2020

BUY
$48.02 - $79.04 $322,550 - $530,911
6,717 Added 21.04%
38,649 $2.83 Million
Q1 2020

May 11, 2020

BUY
$36.95 - $62.95 $289,872 - $493,842
7,845 Added 32.57%
31,932 $1.66 Million
Q4 2019

Feb 13, 2020

BUY
$47.06 - $56.64 $211,534 - $254,596
4,495 Added 22.94%
24,087 $1.36 Million
Q3 2019

Nov 12, 2019

BUY
$47.45 - $58.05 $24,911 - $30,476
525 Added 2.75%
19,592 $934,000
Q2 2019

Aug 13, 2019

BUY
$39.26 - $54.21 $230,613 - $318,429
5,874 Added 44.52%
19,067 $1.03 Million
Q1 2019

May 14, 2019

BUY
$29.84 - $43.92 $52,816 - $77,738
1,770 Added 15.5%
13,193 $536,000
Q4 2018

Feb 14, 2019

SELL
$29.95 - $46.34 $321,752 - $497,830
-10,743 Reduced 48.47%
11,423 $356,000
Q3 2018

Nov 13, 2018

BUY
$40.12 - $45.55 $251,873 - $285,962
6,278 Added 39.51%
22,166 $1.01 Million
Q2 2018

Aug 13, 2018

SELL
$38.72 - $42.52 $4,065 - $4,464
-105 Reduced 0.66%
15,888 $666,000
Q1 2018

May 15, 2018

BUY
$39.4 - $47.39 $630,124 - $757,908
15,993 New
15,993 $657,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Blair William & CO Portfolio

Follow Blair William & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.